Dr Deepakkumar Langade
vidwan id: 115552
Professor, Pharmacology
Padmashree Dr D Y Patil Vidyapeeth, Mumbai
Expertise
- Medicine Research and Experimental
Publications
Publications
No publication activity to display at the moment.
Scopus
h-index
6
CrossRef
Citations
22
h-index
2
Google Scholar
Loading Scholar statistics...
Professional Recognition
VL Sovoni Prize
University of PuneGufic Prize
Indian Pharmacological Society (IPS)Community & Membership
Institutional Ethics Committee (IEC) for CT & BABE
Member secretaryInstitutional Animal Ethics Committee (IAEC)
ChairmanPharmacovigilance Committee
ChairmanInstitutional Ethics Committee (IEC) for Biomedical Research
MemberInstitutional Ethics Committee Terna Dental College, Navi Mumbai
ChairmanInstitutional Ethics Committee MGM Dental College, Navi Mumbai
ChairmanNational Association of Pharmacology and Therapeutics
Medical Pharmacologists Society (MPS)
BODHI
Research Society, Bharati Vidyapeeth Medical College
Indian Pharmacological Society (IPS)
Research Society, B J Medical College, Pune
Bio
Clinical Pharmacologist, Bio-statistician, GCP expert, Ethics in Research, Research Methodology, Pre-clinical Pharmacology, Clinical trials, Plant medicine
Personal Details
- Male
- Professor , Padmashree Dr D Y Patil Vidyapeeth, Mumbai
- Padmashree Dr. D Y Patil University, Navi Mumbai
Related Profiles
Experts (157+)
View All
Assistant Professor
Assistant Professor
Assistant Professor
Physical Director
Assistant Professor
Assistant Professor
Dr Jyothi Alias Jyotsna Baragi
Assistant Professor
Assistant Professor
Professor
N/A
Organisations (341+)
View All
Dean
Assistant Professor
Assistant Professor
Assistant Professor
Associate Professor
Associate Professor
Assistant Professor
Assistant Professor
Associate Professor
Associate Professor
Co-Authors (8)
Bharati Vidyapeeth
Bharati Vidyapeeth
Bhaikaka University, Karamsad
DHARMAJ DEGREE PHARMACY COLLEGE, DHARMAJ 241
Bharati Vidyapeeth
Bharati Vidyapeeth
Dayananda Sagar College of Dental Sciences
Scholarly Work
Effect of commonly used psychotropic drugs on the gut-brain axis in Sprague-Dawley rats
Funding Agency: Padmashree Dr. D Y Patil Vidyapeeth
Principal Investigator
1,000,000
2022 - Ongoing
Effects of Common Herbal Extracts (Cinnamon, Garlic, Ginger, Curcumin, Ashwagandha, Aloe vera) and Drugs (Artemisinin, Aspirin, Hydroxychloroquine, Glipizide, Metformin, Melatonin) on Angiogenesis in the Chick Embryo Chorioallantoic Membrane (CAM)
Funding Agency: Padmashree Dr. D Y Patil Vidyapeeth
Principal Investigator
1,138,600
2022 - Ongoing
Evaluation of effect of Moringa oliefera extract on oxidative stress and exercise capacity in healthy adults: A Prospective, Randomized, Placebo-Controlled Study
Funding Agency: Padmashree Dr. D Y Patil Vidyapeeth
Principal Investigator
1,600,000
2022 - Ongoing
Evaluation of Ashwagandha (Withania Somnifera) Standardized Extract for its effect on quality of life (QoL) in patients during post-COVID19 period: A Prospective, Randomized, Placebo-Controlled Study
Funding Agency: Padmashree Dr. D Y Patil Vidyapeeth
Co-Investigator
720,000
2021 - Ongoing
A randomized, double-blind, placebo control, multicenter, clinical trial to evaluate the efficacy and safety of intravenous (IV) Rabeprazole in prevention of pulmonary acid
Funding Agency: Cadila Pharma
Co-Investigator
250,000
2019 - Ongoing
Awareness of Drug Safety Reporting Among Healthcare Professionals in a Tertiary Care Teaching Hospital
Funding Agency: DY Patil University School of Medicine
Principal Investigator
10,000
2019 - Ongoing
Telemedicine in Primary Health Care Delivery: A mixed methods assessment in remote areas of Khamar
Funding Agency: John Hopkins University
Co-Investigator
100,000
2019 - Ongoing
Burnout in Healthcare Professionals at a Tertiary Healthcare Teaching Institute in Navi Mumbai
Funding Agency: DY Patil University School of Medicine
Principal Investigator
INDIA: A Questionna
2018 - 2019
Clinical Evaluation of Ashwagandha Standardized Extract (KSM 66) for its Pharmacological Actions on Sleep in Subjects Having Insomnia and Healthy Subjects: A Prospective, Randomized, Double-blind, Placebo-Controlled Study
Funding Agency: Self-funded
Principal Investigator
0
2018 - 2020
Burnout in Healthcare Professionals at a Tertiary Healthcare Teaching Institute in Navi Mumbai INDIA: A Questionnaire Based Study
Funding Agency: DY Patil University School of Medicine
Principal Investigator
10,000
2018 - Ongoing
Prospective
Funding Agency: Double-Blind
Multi-centric
-0001 - Ongoing
Prospective Observational Real-World Study of Efficacy and Safety of Azilsartan Using Ambulatory Blood Pressure Monitoring (ABPM) over 6 Weeks of Treatment in Patients with Essential Hypertension in Western India
Funding Agency: Self-funded
0
-0001 - Ongoing
Evaluation of a digitally assisted history-taking tool (HxGuide) by community health workers
Funding Agency: John Hopkins University
100,000
-0001 - Ongoing
A prospective
Funding Agency: tolerability
dose escalation pha
-0001 - Ongoing
A Phase IV Open-Label
Funding Agency: Multicenter Study in Previously Unvaccinated Immunocompromised Adults to Determine the Immunogenicity and Safety of AZD1222 Vaccine for the Prevention of COVID-19
Multi-Cohort
-0001 - Ongoing
A Randomized
Funding Agency: Perceived Alertness & Digital Fatigue for Video Gamers
Double-blind Crosso
-0001 - Ongoing
A Randomized
Funding Agency: Ongoing
Placebo Controlled
-0001 - Ongoing
Long Term Safety and Efficacy of KSM-66 Ashwagandha (Standardized root extract of Withania Somnifera) in Adults: A Prospective
Funding Agency: 0
Ongoing
-0001 - Ongoing
Comparative Evaluation of Ashwagandha Standardized Extract and Melatonin on Sleep in Subjects Having Insomnia: A Prospective
Funding Agency: Double-Blind
Double-Dummy
-0001 - Ongoing
Burnout in Healthcare Professionals at a Tertiary Healthcare Teaching Institute in Navi Mumbai
Funding Agency: Complete
INDIA: A Questionna
-0001 - Ongoing
Awareness of Drug Safety Reporting Among Healthcare Professionals in a Tertiary Care Teaching Hospital
Funding Agency: Self-funded
0
-0001 - Ongoing
Prospective
Funding Agency: Double-Blind
Multi-centric
-0001 - Ongoing
Prospective Observational Real-World Study of Efficacy and Safety of Azilsartan Using Ambulatory Blood Pressure Monitoring (ABPM) over 6 Weeks of Treatment in Patients with Essential Hypertension in Western India
Funding Agency: Self-funded
0
-0001 - Ongoing
Telemedicine in Primary Health Care Delivery: A mixed methods assessment in remote areas of Khamar
Funding Agency: Ongoing
Odisha
-0001 - Ongoing
Evaluation of a digitally assisted history-taking tool (HxGuide) by community health workers
Funding Agency: John Hopkins University
100,000
-0001 - Ongoing
A phase III
Funding Agency: double blind
multi-centre
-0001 - Ongoing
A prospective
Funding Agency: tolerability
dose escalation pha
-0001 - Ongoing
A Phase IV Open-Label
Funding Agency: Multicenter Study in Previously Unvaccinated Immunocompromised Adults to Determine the Immunogenicity and Safety of AZD1222 Vaccine for the Prevention of COVID-19
Multi-Cohort
-0001 - Ongoing
A Randomized
Funding Agency: Perceived Alertness & Digital Fatigue for Video Gamers
Double-blind Crosso
-0001 - Ongoing
A Randomized
Funding Agency: Ongoing
Placebo Controlled
-0001 - Ongoing
Long Term Safety and Efficacy of KSM-66 Ashwagandha (Standardized root extract of Withania Somnifera) in Adults: A Prospective
Funding Agency: 0
Ongoing
-0001 - Ongoing
COMPARISION OF THE EFFECT OF OLANZAPINE AND QUETIAPINE ON BLOOD GLUCOSE LEVELS
COMPARATIVE STUDY OF EFFICACY AND SAFETY OF ATORVASTATIN AND FEBUXOSTAT WITH ATORVASTATIN IN SECONDARY DYSLIPIDAEMIA
No Data Found
There is currently nothing to display here.
